We are a biotechnology company specializing in immuno-oncology, target exploration, and genetic modification. Our focus is on creating highly potent and secure immunotherapies tailored to combat various forms of cancer. We are dedicated to expanding the advantages of immunotherapy through the utilization of DIAMOND AI (Kiromic Diamond Artificial Intelligence), a versatile computational platform designed to uncover novel cancer-related targets for T-Cells and B-Cells.
Kiromic Biopharma
Headquarters
United States of America